Status:
NOT_YET_RECRUITING
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Lead Sponsor:
University of Utah
Conditions:
NSCLC Stage II
NSCLC, Stage III
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal ...
Detailed Description
This is a pilot study evaluating the feasibility of the Precision Exercise Regimen for Cancer Care (PERCC) intervention in stage II and stage III Non-Small Cell Lung Cancer (NSCLC) patients receiving ...
Eligibility Criteria
Inclusion
- Ages 18 and older at time of diagnosis
- Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC)
- Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery
- Patient able to follow direction and complete questionnaires in English or Spanish
- Patient agrees to complete the PERCC intervention
Exclusion
- Morbidly obese (BMI \>40 kg/m2 ) or anorexic (BMI \<17.5 kg/m2 )
- Abnormalities on screening physical exam per study physicians or physical therapist to contraindicate participation in exercise program compliance
- Alcohol or drug abuse, significant mental or emotional problems that would interfere with compliance (assessed by NCCN Distress Thermometer)
- Patient scheduled to receive single modality cancer treatment (unimodal therapy), scheduled to begin treatment within 2 weeks of the pre-treatment clinic visit, or for whom treatment has already started
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06945484
Start Date
December 1 2025
End Date
December 1 2030
Last Update
November 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Medical Branch at Galveston
Galveston, Texas, United States, 77555
2
Huntsman Cancer Institute
Salt Lake City, Utah, United States, 84112